(Q28293268)

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

13 July 2024

1 reference

hypoactive sexual desire disorder

1 reference

1

Stephen M Stahl

0 references

author name string

Bernd Sommer

2

0 references

Stephen M. Stahl

1

1 reference

Europe PubMed Central

PubMed publication ID

20840530

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840530

13 July 2024

Kelly A. Allers

3

1 reference

Europe PubMed Central

PubMed publication ID

20840530

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840530

13 July 2024

language of work or name

English

0 references

publication date

January 2011

0 references

14 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

20840530

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20840530

full work available at URL

13 July 2024

number of pages

13

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S1743609515332252?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

https://api.elsevier.com/content/article/PII:S1743609515332252?httpAccept=text/plain

13 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

https://academic.oup.com/jsm/article-pdf/8/1/15/47245051/jsm_8_1_15.pdf

13 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

The Journal of Sexual Medicine

13 July 2024

published in

0 references

volume

8

0 references

issue

1

0 references

page(s)

15-27

0 references

cites work

Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.

8

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study

13 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex

13 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

BIMT 17: a putative antidepressant with a fast onset of action?

13 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Behavioral effects of flibanserin (BIMT 17).

13 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Further characterisation of potential antidepressant action of flibanserin

13 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Mechanism of action of flibanserin in the learned helplessness paradigm in rats

13 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats.

13 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Pharmacology of flibanserin

13 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Effect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain

13 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats

13 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors

13 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain

13 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety

13 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain

13 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain

13 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors

13 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Pathways of sexual desire

13 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Multifunctional drugs: a novel concept for psychopharmacology

13 July 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity

13 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells

13 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist

13 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction

13 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Activation of G proteins and extracellular signal-regulated kinase 1/2 phosphorylation via human dopamine D4.4 receptors: differential pathway-dependent potencies of receptor agonists

13 July 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain

13 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.

13 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

13 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

13 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

13 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

13 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity

13 July 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

13 July 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Retrograde double-labeling study of common afferent projections to the dorsal raphe and the nuclear core of the locus coeruleus in the rat.

13 July 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool.

13 July 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

13 July 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.

13 July 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons

13 July 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets

13 July 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Noradrenergic modulation of arousal

13 July 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement

13 July 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Functional diversity of ventral midbrain dopamine and GABAergic neurons

13 July 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications

13 July 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study

13 July 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus

13 July 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex

13 July 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs

13 July 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

13 July 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

13 July 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study

13 July 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X

Cues resulting in desire for sexual activity in women

13 July 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1743-6109.2010.02032.X